These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8383343)

  • 1. An ACTH/MSH(4-9) analog counteracts the behavioral effects of a mineralocorticoid receptor antagonist.
    Oitzl MS; Josephy M; Spruijt BM
    Pharmacol Biochem Behav; 1993 Feb; 44(2):447-50. PubMed ID: 8383343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Org2766 improves performance of rats with unilateral lesions in the fimbria fornix in a spatial learning task.
    Spruijt B; Pitsikas N; Algeri S; Gispen WH
    Brain Res; 1990 Sep; 527(2):192-7. PubMed ID: 2174715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ACTH(4-9) analog Org2766 modulates the behavioral changes induced by NMDA and the NMDA receptor antagonist AP5.
    Spruijt BM; Josephy M; Van Rijzingen I; Maaswinkel H
    J Neurosci; 1994 May; 14(5 Pt 2):3225-30. PubMed ID: 7910205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ACTH/MSH (4-9) analog Org2766 improves retrieval of information after a fimbria fornix transection.
    Pitsikas N; Spruijt BM; Algeri S; Gispen WH
    Peptides; 1990; 11(5):911-4. PubMed ID: 2178248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Org2766, an ACTH(4-9) analogue, on recovery after bilateral transection of the fimbria fornix in the rat.
    Pitsikas N; Spruijt BM; Josephy M; Algeri S; Gispen WH
    Pharmacol Biochem Behav; 1991 Apr; 38(4):931-4. PubMed ID: 1651522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of an ACTH-(4-9) analog (Org2766) in the treatment of experimental cortex lesion in rats.
    Zhang S; He L; Fu J; Zhang M; Zhang Y
    Chin Med Sci J; 1994 Mar; 9(1):12-5. PubMed ID: 8086627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related facilitation and inhibition of passive avoidance behavior by the ACTH 4-9 analog (ORG 2766).
    Fekete M; De Wied D
    Pharmacol Biochem Behav; 1982 Aug; 17(2):177-82. PubMed ID: 6291064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MSH/ACTH(4-9) analog Org2766 counteracts isolation-induced enhanced social behavior via the amygdala.
    Hol T; Spruijt BM
    Peptides; 1992; 13(3):541-4. PubMed ID: 1326104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTH(4-9) analog ORG2766 treatment 7 months delayed still improves morris maze performance of fimbria-lesioned rats.
    Van Rijzingen IM; Van Doremalen E; Josephy M; Gispen WH; Spruijt BM
    Pharmacol Biochem Behav; 1996 Jan; 53(1):163-9. PubMed ID: 8848446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent upregulation of hippocampal mineralocorticoid receptors after neonatal administration of ACTH-(4-9) analog ORG 2766 in rats.
    Nyakas C; Felszeghy K; Bohus B; Luiten PG
    Brain Res Dev Brain Res; 1997 Apr; 99(2):142-7. PubMed ID: 9125467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
    Souness GW; Morris DJ
    Endocrinology; 1991 Nov; 129(5):2451-6. PubMed ID: 1657575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency and duration of action of the ACTH 4-9 analog (ORG 2766) as compared to ACTH 4-10 and [D-Phe7] ACTH 4-10 on active and passive avoidance behavior of rats.
    Fekete M; De Wied D
    Pharmacol Biochem Behav; 1982 Mar; 16(3):387-92. PubMed ID: 6281814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
    Spencer RL; Kim PJ; Kalman BA; Cole MA
    Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postnatal treatment with ACTH4-9 analog ORG 2766 improves adult spatial learning but does not affect behavioural stress reactivity.
    Horváth KM; Meerlo P; Felszeghy K; Nyakas C; Luiten PG
    Behav Brain Res; 1999 Dec; 106(1-2):181-8. PubMed ID: 10595434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential behavioral effects of ACTH 4-10 and [D-Phe7] ACTH 4-10.
    Wiegant VM; Colbern D; van Wimersma Greidanus TJ; Gispen WH
    Brain Res Bull; 1978; 3(2):167-70. PubMed ID: 206319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral activity of a short chain ACTH analog.
    Drago F; Continella G; Scapagnini U
    Pharmacol Biochem Behav; 1984 May; 20(5):689-95. PubMed ID: 6330764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial learning and the hippocampal corticosterone receptor system of old rats: effect of the ACTH4-9 analogue ORG 2766.
    Rigter H; Veldhuis HD; de Kloet ER
    Brain Res; 1984 Sep; 309(2):393-8. PubMed ID: 6089963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mineralocorticoid agonist and antagonist specific receptors from rat kidney.
    Agarwal MK; Kalimi M
    Biochem Biophys Res Commun; 1987 Feb; 143(1):398-402. PubMed ID: 3030321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic administration of Org2766 and morphine counteracts isolation-induced increase in social interest: implication of endogenous opioid systems.
    Hol T; Ruven S; Van Ree JM; Spruijt BM
    Neuropeptides; 1996 Jun; 30(3):283-91. PubMed ID: 8819152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the ACTH4-9 analog Org2766 on brain plasticity: modulation of excitatory neurotransmission?
    Spruijt BM
    Psychoneuroendocrinology; 1992 Aug; 17(4):315-25. PubMed ID: 1332099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.